Small intestinal bacterial overgrowth: Duodenal aspiration vs glucose breath test

Neurogastroenterology and Motility

Volumn 27, Issue 4, 2015, Pages 481-489

  Erdogan, A ^a   Rao, S S C ^a   Gulley, D ^a   Jacobs, C ^b   Lee, Y Y ^a,c   Badger, C ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Duodenal culture; Ethnics; Glucose breath test; Sensitivity and specificity; Small intestinal bacterial overgrowth

Indexed keywords

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIUM CULTURE; BLOATING; BREATH ANALYSIS; CLINICAL TRIAL; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIARRHEA; DUODENAL ASPIRATION; DUODENAL CULTURE; ENDOSCOPIC BIOPSY; ESCHERICHIA COLI; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; GLUCOSE BREATH TEST; HUMAN; INTERMETHOD COMPARISON; INTESTINE EXAMINATION; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION DISTRIBUTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; UNITED STATES; BACTERIAL INFECTIONS; DUODENUM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES;

GLUCOSE;

BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BREATH TESTS; DUODENUM; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84925656503     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12516     Document Type: Article

References (48)

1. Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Therapeutic advances in chronic disease 2013; 4: 223-31.
2. Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther 2013; 37: 1103-11.
3. Holt PR. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am 2001; 30: 427-44.
4. Ghoshal UC, Ghoshal U, Ayyagari A, Ranjan P, Krishnani N, Misra A, Aggarwal R, Naik S et al. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J Gastroenterol Hepatol 2003; 18: 540-7.
5. Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
6. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol 2014; 12: 1964-72.
7. Hamilton I, Worsley BW, Cobden I, Cooke EM, Shoesmith JG, Axon AT. Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut 1982; 23: 847-53.
8. Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, Akkermans LM. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol 2008; 42: 1095-102.
9. Tabaqchali S. The pathophysiological role of small intestinal bacterial flora. Scand J Gastroenterol Suppl 1970; 6: 139-63.
10. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. The American journal of gastroenterology 2002; 97: 1113-26.
11. Jones HF, Davidson GP, Brooks DA, Butler RN. Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms? J Pediatr Gastroenterol Nutr 2011; 52: 632-4.
12. Majewski M, Reddymasu SC, Sostarich S, Foran P, McCallum RW. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. The American journal of the medical sciences 2007; 333: 266-70.
13. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1157-60.
14. Sabate JM, Jouet P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008; 18: 371-7.
15. Ratuapli SK, Ellington TG, O'Neill MT, Umar SB, Harris LA, Foxx-Orenstein AE, Burdick GE, Dibaise JK et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. The American journal of gastroenterology 2012; 107: 730-5.
16. Gabrielli M, D'Angelo G, Di Rienzo T, Scarpellini E, Ojetti V. Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci 2013; 17(Suppl. 2): 30-5.
17. Bauer TM, Schwacha H, Steinbruckner B, Brinkmann FE, Ditzen AK, Kist M, Blum HE. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000; 33: 382-6.
18. Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion 2012; 85: 243-7.
19. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10.
20. Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009; 29: 1273-81.
21. Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci 2008; 53: 1246-51.
22. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-8.
23. Madrid AM, Poniachik J, Quera R, Defilippi C. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci 2011; 56: 155-60.
24. Rana SV, Sharma S, Sinha SK, Kaur H, Sikander A, Singh K. Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India. Dig Dis Sci 2009; 54: 132-5.
25. Ghoshal UC. How to interpret hydrogen breath tests. Journal of neurogastroenterology and motility 2011; 17: 312-7.
26. Carrara M, Desideri S, Azzurro M, Bulighin GM, Di Piramo D, Lomonaco L, Adamo S. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2008; 12: 197-202.
27. Mac Mahon M, Gibbons N, Mullins E, O'Moore RR, Keane CT, Walsh JB, Coakley D. Are hydrogen breath tests valid in the elderly? Gerontology 1996; 42: 40-5.
28. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000; 14: 551-6.
29. Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol 2011; 26(Suppl. 3): 135-8.
30. Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol 2010; 10: 23.
31. Choi YK, Johlin FC Jr, Summers RW, Jackson M, Rao SS. Fructose intolerance: an under-recognized problem. The American journal of gastroenterology 2003; 98: 1348-53.
32. Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol 2008; 42: 233-8.
33. Bures J, Cyrany J, Kohoutova D, Forstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90.
34. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 982-8.
35. Population Distribution by Race/Ethnicity, 2013. Available at: http://kff.org/other/state-indicator/distribution-by-raceethnicity/-notes.
36. Quigley EM. Small intestinal bacterial overgrowth: what it is and what it is not. Curr Opin Gastroenterol 2014; 30: 141-6.
37. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53: 1443-54.
38. Bardhan PK, Gyr K, Beglinger C, Vogtlin J, Frey R, Vischer W. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol 1992; 27: 253-6.
39. Shindo K, Machida M, Miyakawa K, Fukumura M. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption. The American journal of gastroenterology 1993; 88: 2084-91.
40. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011; 33: 1059-67.
41. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57: 1321-9.
42. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. The American journal of gastroenterology 2003; 98: 412-9.
43. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. The American journal of gastroenterology 2008; 103: 958-63.
44. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, Parodi A, Usai-Satta P et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29(Suppl. 1): 1-49.
45. Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, Avanzini P, Chezzi C et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 302-9.
46. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852-8.
47. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. The American journal of gastroenterology 2000; 95: 3503-6.
48. Elphick DA, Chew TS, Higham SE, Bird N, Ahmad A, Sanders DS. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology 2005; 51: 396-401.